These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2912354)

  • 1. Bronchoalveolar lavage cell and lymphocyte phenotype profiles in healthy asbestos-exposed shipyard workers.
    Wallace JM; Oishi JS; Barbers RG; Batra P; Aberle DR
    Am Rev Respir Dis; 1989 Jan; 139(1):33-8. PubMed ID: 2912354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asbestos exposure and asbestos-related pleural and parenchymal disease. Associations with immune imbalance.
    Sprince NL; Oliver LC; McLoud TC; Eisen EA; Christiani DC; Ginns LC
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):822-8. PubMed ID: 1826194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease.
    Schwartz DA; Galvin JR; Merchant RK; Dayton CS; Burmeister LF; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):400-5. PubMed ID: 1736749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subpopulations in bronchoalveolar lavage fluid in asbestos workers.
    Gellert AR; Macey MG; Uthayakumar S; Newland AC; Rudd RM
    Am Rev Respir Dis; 1985 Oct; 132(4):824-8. PubMed ID: 3840341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of bronchoalveolar lavage in demonstrating previous exposure to asbestos].
    Rivolta G; Prandi E; Sogliani M; Picchi O
    Med Lav; 2001; 92(3):166-72. PubMed ID: 11515149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.
    Garcia JG; Griffith DE; Cohen AB; Callahan KS
    Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos.
    Brunetti G; Delmastro M; Fonte R; Moscato G; Bossi A; Baiardi P; Massola A; Meloni F
    G Ital Med Lav Ergon; 2003; 25(2):152-60. PubMed ID: 12872499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid.
    Schwartz DA; Galvin JR; Burmeister LF; Merchant RK; Dayton CS; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):684-8. PubMed ID: 1892311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage and 99mTc-DTPA clearance as prognostic factors in asbestos workers with and without asbestosis.
    al Jarad N; Gellert AR; Rudd RM
    Respir Med; 1993 Jul; 87(5):365-74. PubMed ID: 8209056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid.
    De Vuyst P; Dumortier P; Moulin E; Yourassowsky N; Yernault JC
    Am Rev Respir Dis; 1987 Nov; 136(5):1219-24. PubMed ID: 3314616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage and clearance of 99m-Tc-DTPA in asbestos workers without evidence of asbestosis.
    Gellert AR; Langford JA; Uthayakumar S; Rudd RM
    Br J Dis Chest; 1985 Jul; 79(3):251-7. PubMed ID: 3893510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage.
    Teschler H; Konietzko N; Schoenfeld B; Ramin C; Schraps T; Costabel U
    Am Rev Respir Dis; 1993 May; 147(5):1211-5. PubMed ID: 8484633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
    Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
    Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma.
    Sebastien P; Armstrong B; Monchaux G; Bignon J
    Am Rev Respir Dis; 1988 Jan; 137(1):75-8. PubMed ID: 3337472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimate of the previous exposure to asbestos through mineralogical examination of the bronchoalveolar lavage (BAL) fluid in a population working in a sugar industry].
    Sartorelli P; Romeo R; Sisinni AG; Paolucci V; Peccetti V; Sallese D; Scancarello G
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):644-6. PubMed ID: 18411447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.
    Cruz MJ; Curull V; Pijuan L; Álvarez-Simón D; Sánchez-Font A; de Gracia J; Culebras M; Ferrer J
    Arch Bronconeumol; 2017 Jun; 53(6):318-323. PubMed ID: 27914752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease.
    Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Ruotsalainen EM; Lähde S; Kinnula VL
    Eur Respir J; 1999 Sep; 14(3):560-4. PubMed ID: 10543275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar cell differential count and the number of asbestos bodies correlate with survival in patients with asbestosis.
    Keskitalo E; Varis L; Bloigu R; Kaarteenaho R
    Occup Environ Med; 2019 Oct; 76(10):765-771. PubMed ID: 31331950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoalveolar lavage fluid cellular profile in workers exposed to chrysotile asbestos.
    Kokkinis FP; Bouros D; Hadjistavrou K; Ulmeanu R; Serbescu A; Alexopoulos EC
    Toxicol Ind Health; 2011 Oct; 27(9):849-56. PubMed ID: 21421677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytoimmunological changes in the bronchoalveolar lavage in asbestos exposure patients].
    Gil K
    Folia Med Cracov; 2006; 47(1-4):21-36. PubMed ID: 18038610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.